P2-329: TRACKING WHITE MATTER DEGENERATION IN ASYMPTOMATIC AND SYMPTOMATIC MAPT MUTATION CARRIERS WITH DTI
Qin Chen,Bradley F. Boeve,Christopher G. Schwarz,Robert I. Reid,Nirubol Tosakulwong,Timothy G. Lesnick,Jessica Bove,P Brannelly,Danielle Brushaber,Giovanni Coppola,Christina Dheel,Brad C. Dickerson,Susan Dickinson,Kelley Faber,Julie A. Fields,Jamie Fong,Tatiana Foroud,Leah K. Forsberg,Ralitza H. Gavrilova,Debra Gearhart,Nupur Ghoshal,Jill Goldman,Jonathan Graff‐Radford,Neill R. Graff‐Radford,Murray Grossman,Dana Haley,Hilary W. Heuer,Ging‐Yuek Robin Hsiung,Edward D. Huey,David J. Irwin,Clifford R. Jack,David T. Jones,Lynne C. Jones,Anna Karydas,David S. Knopman,John Kornak,Joel H. Kramer,Walter K. Kremers,Walter A. Kukull,Maria I. Lapid,Diane Lucente,Codrin Lungu,Ian R. Mackenzie,Masood Manoochehri,Scott McGinnis,Bruce L. Miller,Rodney Pearlman,Leonard Petrucelli,Madeline Potter,Rosa Rademakers,Eliana Marisa Ramos,Katherine P. Rankin,Katya Rascovsky,Pheth Sengdy,Leslie M. Shaw,Jeremy Syrjanen,Nadine Tatton,Joanne Taylor,Arthur W. Toga,John Q. Trojanowski,Sandra Weıntraub,Bonnie Wong,Adam L. Boxer,Howard J. Rosen,Zbigniew K. Wszołek,Kejal Kantarci
DOI: https://doi.org/10.1016/j.jalz.2019.06.2736
2019-01-01
Abstract:White matter injury caused by tau pathology is commonly observed in postmortem examinations of genetic and sporadic cases of patients with frontotemporal lobar degeneration. The objective of this study was to investigate the patterns and trajectories of white matter (WM) diffusion abnormalities in microtubule-associated protein tau (MAPT) mutations carriers. We studied 22 MAPT mutation carriers (12 asymptomatic, 10 symptomatic) and 20 non-carriers from 8 individual families, who underwent diffusion tensor imaging (DTI) and were followed annually (median=4 years) from the Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects Study at the Mayo Clinic sites. Cross-sectional and longitudinal changes in mean diffusivity (MD) and fractional anisotropy (FA) were analyzed. The mean of the tract-based values derived from white matter John's Hopkins University atlas combing the right and left hemispheric regions were determined. We ranked the 43 regions of interest according to the area-under-the-receiver-operating-characteristics curves for distinguishing asymptomatic and symptomatic MAPT mutation carriers from non-carriers using baseline MD and FA values. The association of MD and FA values with time to expected age of onset and time past age of onset were tested using multiple linear regression analysis after adjusting for age. To assess the longitudinal abnormalities, the annual changes in MD and FA were modeled to compare MAPT mutation carriers to non-carriers using linear mixed-effect models. We found that elevated MD in the entorhinal white matter is present as early as the asymptomatic stage in MAPT mutation carriers (p=0.046), which propagated to the limbic tracts and frontotemporal projections in the symptomatic stage compared to non-carriers (Figure 1). Reduced FA (p<0.001) and increased MD (p=0.004) in the entorhinal white matter were associated with the proximity to estimated and actual age of symptom onset. The annualized change of entorhinal MD on serial DTI was accelerated in MAPT mutation carriers compared to non-carriers (p=0.002, Figure 2).